JD Health International Inc. submitted its October 2025 Monthly Return for Equity Issuer, confirming no changes in both authorized share capital and overall issued shares. The total authorized share capital remained USD 50,000, with 100,000,000,000 ordinary shares at a par value of USD 0.0000005 each. The issued share count stood at 3,201,475,111, unchanged from the previous month, and there were no treasury shares.

Under the Pre-IPO ESOP, 8,856,023 options were exercised using previously issued shares, and 6,660 options lapsed. These exercises generated USD 4.43 in total. By the end of October, 11,387,260 share options remained outstanding in this scheme. Meanwhile, the Post-IPO Share Option Scheme had no new activity, leaving up to 312,708,211 shares permissible for issuance under that framework.

The Post-IPO Share Award Scheme reported 24,799,005 shares remaining available for issuance. The report was submitted by Director Dong Cao on November 6, 2025.